INTERNATIONAL STEM CELL CORPORATION (ISCO) Operating income 2016–2025
INTERNATIONAL STEM CELL CORPORATION (ISCO) annual operating income history from SEC filings — each fiscal year as reported.
-$267,000FY2025 · since FY2016: -$4.9M → -$267,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$267,000 | -292.6% |
| FY2024 | -$68,000 | +89.7% |
| FY2023 | -$663,000 | -262.3% |
| FY2022 | -$183,000 | +90.5% |
| FY2021 | -$1.9M | +31.8% |
| FY2020 | -$2.8M | +50.8% |
| FY2019 | -$5.7M | -64.9% |
| FY2018 | -$3.5M | +29.7% |
| FY2017 | -$4.9M | -1.9% |
| FY2016 | -$4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ISCO financial trends
ISCO RevenueISCO Net incomeISCO Net marginISCO Gross profitISCO Gross marginISCO Operating marginISCO Operating cash flowISCO Free cash flowISCO Capital expendituresISCO Return on equityISCO Stock buybacksISCO Dividends paidISCO Total assetsISCO Total liabilitiesISCO Shareholders’ equityISCO overview →